PPAR Research · 2020 · 22 citations · 16 references
Life SciencesMolecular BiologyOncologyCancer GeneticsGene ExpressionMolecular OncologyCancer Cell SignalingCancer GenomicsCancer TranscriptomicsMolecular Tumor ProfilingNuclear Receptor SignalingNuclear ReceptorsDifferential Co-expression AnalysisDifferential Protein Expression AnalysisImmune Cell Subtype ClassificationMicroarray Differential Expression AnalysisNuclear Receptor TargetsPeroxisome Proliferator-activated Receptor Alpha (Ppar-alpha) SignalingPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
Peroxisome proliferator-activated receptors (PPARs) are members of nuclear transcription factors. The functions of the PPAR family (PPARA, PPARD, and PPARG) and their coactivators (PPARGC1A and PPARGC1B) in maintenance of lipid and glucose homeostasis have been unveiled. However, the roles of PPARs in cancer development remain elusive. In this work, we made use of 11,057 samples across 33 TCGA tumor types to analyze the relationship between PPAR transcriptional expression and tumorigenesis as well as drug sensitivity. We performed multidimensional analyses on PPARA, PPARG, PPARD, PPARGC1A, and PPARGC1B, including differential expression analysis in pan-cancer, immune subtype analysis, clinical analysis, tumor purity analysis, stemness correlation analysis, and drug responses. PPARs and their coactivators expressed differently in different types of cancers, in different immune subtypes. This analysis reveals various expression patterns of the PPAR family at a level of pan-cancer and provides new clues for the therapeutic strategies of cancer.
16
Damian Szklarczyk, Annika L. Gable, David Lyon et al. · Nucleic Acids Research · 2018 · 19.2K citations · Full text
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · Nature Communications · 2013 · 10.7K citations · Full text
The Immune Landscape of Cancer
Vésteinn Thórsson, David L. Gibbs, Scott D. Brown et al. · Immunity · 2018 · 6.2K citations · Full text
Medicine, Immunology, Oncology +17
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta, Artem Sokolov, Andrew J. Gentles et al. · Cell · 2018 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
Telomere dysfunction induces metabolic and mitochondrial compromise
Ergün Sahin, Simona Colla, Marc Liesa et al. · Nature · 2011 · 1.3K citations